{"transactions":[{"id":897531,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":65949,"kind":"person","name":"Hodgson Ian","position":1,"cik":"0002057525","reported_name":"Hodgson Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-18T16:32:02.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":847,"price":7.383,"value":6253.401,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.37 to $7.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 46,362 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":51080,"source":{"system":"sec-edgar","filing":"0001193125-26-057174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057525/000119312526057174/ownership.xml","form_type":"4"}},{"id":919755,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":65949,"kind":"person","name":"Hodgson Ian","position":1,"cik":"0002057525","reported_name":"Hodgson Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-04T16:24:39.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":2415,"price":8.0899,"value":19537.1085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 48,108 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":51927,"source":{"system":"sec-edgar","filing":"0001193125-26-037643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057525/000119312526037643/ownership.xml","form_type":"4"}},{"id":937487,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":65949,"kind":"person","name":"Hodgson Ian","position":1,"cik":"0002057525","reported_name":"Hodgson Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-01-16T16:30:03.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":85095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 14, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 14, 2027."}],"balance_after":85095,"derivative":{"exercise_price":8.26,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":85095},"source":{"system":"sec-edgar","filing":"0001193125-26-015430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2057525/000119312526015430/ownership.xml","form_type":"4"}},{"id":937486,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":65949,"kind":"person","name":"Hodgson Ian","position":1,"cik":"0002057525","reported_name":"Hodgson Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-01-16T16:30:03.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":28365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 14, 2026, the Reporting Person was granted 28,365 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 14, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 53,108 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":54342,"source":{"system":"sec-edgar","filing":"0001193125-26-015430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057525/000119312526015430/ownership.xml","form_type":"4"}}]}